{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:32:47Z","timestamp":1791988367926,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"17","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.vaccine.2014.01.062","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T17:00:34Z","timestamp":1392138034000},"page":"1954-1963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa"],"prefix":"10.1016","volume":"32","author":[{"given":"Sun-Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise B.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeehyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Verani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare L.","family":"Cutland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie J.","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushua","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement 4","key":"10.1016\/j.vaccine.2014.01.062_bib0005","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2013.01.009","article-title":"An overview of global GBS epidemiology","volume":"31","author":"Le Doare","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis","volume":"379","author":"Edmond","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1179\/000349803125002814","article-title":"High burden of invasive Streptococcus agalactiae disease in South African infants","volume":"23","author":"Madhi","year":"2003","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0020","first-page":"858","article-title":"Is prophylaxis of early-onset group B streptococcal disease appropriate for South Africa","volume":"91","author":"Bomela","year":"2001","journal-title":"S Afr Med J"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0025","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(09)61339-8","article-title":"Chlorhexidine maternal\u2013vaginal and neonate body wipes in sepsis and vertical transmission of pathogenic bacteria in South Africa: a randomised, controlled trial","volume":"374","author":"Cutland","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0030","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1542\/peds.2011-1548","article-title":"Maternal HIV infection and vertical transmission of pathogenic bacteria","volume":"130","author":"Cutland","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0035","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1086\/323350","article-title":"Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study","volume":"184","author":"Lin","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0040","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1086\/422756","article-title":"Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen","volume":"190","author":"Lin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0045","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/adc.88.5.375","article-title":"Group B streptococcal conjugate vaccines","volume":"88","author":"Baker","year":"2003","journal-title":"Arch Dis Child"},{"issue":"Supplement 4","key":"10.1016\/j.vaccine.2014.01.062_bib0050","doi-asserted-by":"crossref","first-page":"D13","DOI":"10.1016\/j.vaccine.2012.12.080","article-title":"A maternal vaccine against group B Streptococcus: past, present, and future","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0055","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/erv.11.61","article-title":"An update on vaccination against group B streptococcus","volume":"10","author":"Heath","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0060","unstructured":"National Library of Medicine (US). ClinicalTrials.gov. http:\/\/www.clinicaltrials.gov www.clinicaltrials.gov (accessed June 7, 2013)."},{"key":"10.1016\/j.vaccine.2014.01.062_bib0065","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010","volume":"59","author":"CDC","year":"2010","journal-title":"Morb Mortal Wkly Rep"},{"issue":"Supplement 4","key":"10.1016\/j.vaccine.2014.01.062_bib0070","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/INF.0b013e31825c4b5a","article-title":"Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa","volume":"31","author":"Schrag","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(10)61932-0","article-title":"Group B streptococcal vaccine for resource-poor countries","volume":"378","author":"Schrag","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0085","series-title":"Recorded live births, 2010","year":"2011"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0090","series-title":"Health Systems Trust","author":"District Health Information System","year":"2010"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0095","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1093\/heapol\/czs005","article-title":"Paying for and receiving benefits from health services in South Africa: is the health system equitable?","volume":"27","author":"Ataguba","year":"2012","journal-title":"Health Policy Plann"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0100","series-title":"Immunization summary: a statistical reference containing data through 2009","author":"UNICEF","year":"2011"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0105","doi-asserted-by":"crossref","first-page":"e17861","DOI":"10.1371\/journal.pone.0017861","article-title":"Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads","volume":"6","author":"Madzivhandila","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0110","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1067\/mob.2001.113875","article-title":"The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease","volume":"184","author":"Lin","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AOG.0b013e318280d4f6","article-title":"Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease","volume":"121","author":"Fairlie","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00006454-199704000-00009","article-title":"Frequency of low level bacteremia in infants from birth to two months of age","volume":"16","author":"Kellogg","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0125","series-title":"World development indicators 2012","year":"2012"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0130","series-title":"Cost-effectiveness in Health and Medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0135","series-title":"The World Health Report 2002: reducing risks, promoting healthy life","author":"WHO","year":"2002"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(98)07128-1","article-title":"Group B streptococcus","volume":"353","author":"Schuchat","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0145","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(05)71877-8","article-title":"WHO estimates of the causes of death in children","volume":"365","author":"Bryce","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(11)61337-8","article-title":"Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis","volume":"378","author":"Lozano","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0155","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/jama.1993.03510120064032","article-title":"Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis","volume":"270","author":"Mohle-Boetani","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0160","series-title":"Vaccines for the 21st century: a tool for decision making: Institute of Medicine","year":"2000"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0165","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1016\/j.vaccine.2004.12.021","article-title":"The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis","volume":"23","author":"Sinha","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11290","article-title":"Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses","volume":"11","author":"Colbourn","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0175","series-title":"Comparison of CHROMagar StrepB, Columbia CNA agar and Lim broth for the isolation of Group B Streptococcus from vaginal and rectal swabs from South Africa","author":"Kwatra","year":"2013"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0185","series-title":"Department of Health, Medical Research Council","author":"South Africa Demographic and Health Survey 2003","year":"2007"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2471\/BLT.08.062554","article-title":"The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity","volume":"88","author":"Beck","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0195","series-title":"The costs of waste management of sharps from immunization activities: a case study from South Africa","author":"Griffiths","year":"2001"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1179\/2046905512Y.0000000010","article-title":"Economic burden of acute lower respiratory tract infection in South African children","volume":"32","author":"Sinha","year":"2012","journal-title":"Paediatr Int Child Health"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2014.01.062_bib0205","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1086\/653560","article-title":"The economic burden of diarrheal disease in a tertiary level hospital, Gauteng, South Africa","volume":"202","author":"MacIntyre","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0210","series-title":"Monthly earnings of South Africans, 2010","year":"2010"},{"key":"10.1016\/j.vaccine.2014.01.062_bib0215","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","year":"2012","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T14:54:50Z","timestamp":1538837690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":43,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0264410X14001145"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}